Indeed, available predictors (eg PD‐L1 expression and amplification, tumour mutation burden and infiltrating lymphocytes) may be burdened by poor prognostic performance, or high cost of the assay, and often require a biopsy to be determined.13 The gene discussed is CD274; the disease is neoplasm.